MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
15.83
-0.08
-0.50%
After Hours: 15.94 +0.11 +0.69% 19:56 04/08 EDT
OPEN
16.38
PREV CLOSE
15.91
HIGH
16.59
LOW
15.74
VOLUME
373.77K
TURNOVER
--
52 WEEK HIGH
31.04
52 WEEK LOW
13.46
MARKET CAP
470.90M
P/E (TTM)
-8.0511
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FLGT last week (0330-0403)?
Weekly Report · 2d ago
Fulgent Genetics announces annual shareholder meeting
Reuters · 03/31 20:19
Weekly Report: what happened at FLGT last week (0323-0327)?
Weekly Report · 03/30 09:53
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
Barchart · 03/25 18:00
Weekly Report: what happened at FLGT last week (0316-0320)?
Weekly Report · 03/23 09:50
Fulgent Genetics Expands Dermatology Footprint With Key Acquisitions
TipRanks · 03/17 21:01
Fulgent Genetics completes acquisition of Bako Diagnostics and StrataDx for USD 56.9 million
Reuters · 03/17 20:31
FULGENT GENETICS COMPLETES ACQUISITION OF BAKO DIAGNOSTICS AND STRATADX
Reuters · 03/17 20:31
More
About FLGT
Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.

Webull offers Fulgent Genetics Inc stock information, including NASDAQ: FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.